{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:37:24Z","timestamp":1792643844465,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T00:00:00Z","timestamp":1255046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10072-009-0167-y","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T15:13:17Z","timestamp":1255014797000},"page":"41-45","source":"Crossref","is-referenced-by-count":49,"title":["Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis"],"prefix":"10.1007","volume":"31","author":[{"given":"Alberto","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Confalonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Cornelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,9]]},"reference":[{"key":"167_CR1","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, future. J Clin Invest 116:2843\u20132854","journal-title":"J Clin Invest"},{"key":"167_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"167_CR3","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia Gravis. Lancet 357:2122\u20132128","journal-title":"Lancet"},{"key":"167_CR4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","volume":"998","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 998:413\u2013423","journal-title":"Ann N Y Acad Sci"},{"key":"167_CR5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","volume":"941","author":"RJ Barohn","year":"1998","unstructured":"Barohn RJ, Mcintire D, Herbelin L, Wolfe GI, Nations S, Bryan W (1998) Reliability testing of the quantitative myasthenia gravis score. Ann NY Acad Sci 941:769\u2013772","journal-title":"Ann NY Acad Sci"},{"key":"167_CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s100720100066","volume":"22","author":"L Pauda","year":"2001","unstructured":"Pauda L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R, Tonali P (2001) Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 22:363\u2013369","journal-title":"Neurol Sci"},{"key":"167_CR7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.1034","volume":"24","author":"RH Paul","year":"2001","unstructured":"Paul RH, Nash J, Cohen RA, Gilchrist JM, Goldstein JM (2001) Quality of life and well-being of patients with myasthenia gravis. Muscle Nerve 24:512\u2013516","journal-title":"Muscle Nerve"},{"key":"167_CR8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/mus.10035","volume":"25","author":"L Padua","year":"2002","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, D\u2019Amico P, Rabini A, Tonali P (2002) Quality of life in patients with myasthenia gravis. Muscle Nerve 25:466\u2013467","journal-title":"Muscle Nerve"},{"key":"167_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1468-1331.2006.01149.x","volume":"13","author":"A Rostedt","year":"2006","unstructured":"Rostedt A, Padua L, St\u00e5lberg EV (2006) Correlation between regional myasthenic weakness and mental aspects of quality of life. Eur J Neurol 13:191\u2013193","journal-title":"Eur J Neurol"},{"key":"167_CR10","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.clinph.2005.05.017","volume":"116","author":"A Rostedt","year":"2005","unstructured":"Rostedt A, Padua L, Stalberg EV (2005) Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients. Clin Neurophysiol 116:2058\u20132064","journal-title":"Clin Neurophysiol"},{"key":"167_CR11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.cnd.0000202223.39994.c0","volume":"7","author":"KR Scott","year":"2006","unstructured":"Scott KR, Kothari MJ (2006) Self-reported pain affects quality of life in Myasthenia Gravis. J Clin Neuromusc Dis 7:110\u2013114","journal-title":"J Clin Neuromusc Dis"},{"key":"167_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000077937","volume":"50","author":"S Happe","year":"2004","unstructured":"Happe S, Klosch G, Zeitlhofer J (2004) Perception of dreams and subjective sleep quality in patients with myasthenia gravis. Neuropsychobiology 50:21\u201327","journal-title":"Neuropsychobiology"},{"key":"167_CR13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","volume":"71","author":"DB Sanders","year":"2008","unstructured":"Sanders DB, Hart IK, Mantegazza R, Shukla SS, Siddiqi ZA, De Baets MH, Melms A, Nicolle MW, Solomons N, Richman DP (2008) An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 71:400\u2013406","journal-title":"Neurology"},{"key":"167_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10072-006-0606-y","volume":"27","author":"A Rostedt","year":"2006","unstructured":"Rostedt A, Padua L, Stalberg EV (2006) Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire. Neurol Sci 27:91\u201396","journal-title":"Neurol Sci"},{"key":"167_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10072-004-0366-5","volume":"25","author":"L Padua","year":"2005","unstructured":"Padua L, Galassi G, Ariatti A, Aprile I, Caliandro P, Evoli A, Pazzaglia C, Tonali P (2005) Myasthenia gravis self-administered questionnaire: development of regional domains. Neurol Sci 25:331\u2013336","journal-title":"Neurol Sci"},{"key":"167_CR16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21016","volume":"38","author":"LL Mullins","year":"2008","unstructured":"Mullins LL, Carpentier MY, Paul RH, Sanders DB, Muscle Study Group (2008) Disease-specific measure of quality of life for Myasthenia Gravis. Muscle Nerve 38:947\u2013956","journal-title":"Muscle Nerve"},{"key":"167_CR17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group (2008) Less is more, or almost as much: a 15-item quality of life instrument for myasthenia gravis. Muscle Nerve 38:957\u2013963","journal-title":"Muscle Nerve"},{"key":"167_CR18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(06)69498-1","volume":"368","author":"M Leonardi","year":"2006","unstructured":"Leonardi M, Bickenbach J, Ustun TB, Kostanjsek N, Chatterji S, MHADIE Consortium (2006) The definition of disability: what is in a name? Lancet 368:1219\u20131221","journal-title":"Lancet"},{"key":"167_CR19","volume-title":"The international classification of functioning, disability and health-ICF","author":"World Health Organisation","year":"2001","unstructured":"World Health Organisation (2001) The international classification of functioning, disability and health-ICF. WHO, Geneva"},{"key":"167_CR20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","volume":"51","author":"G Apolone","year":"1998","unstructured":"Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025\u20131036","journal-title":"J Clin Epidemiol"},{"key":"167_CR21","volume-title":"WHO-DAS II Field Trials Report 1998","author":"TB Ustun","year":"1999","unstructured":"Ustun TB (1999) WHO-DAS II Field Trials Report 1998. WHO, Geneva"},{"key":"167_CR22","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","volume":"64","author":"RS Bedlack","year":"2005","unstructured":"Bedlack RS, Simel DL, Bosworth H, Samsa B, Tucker-Lipscomb B, Sanders DB (2005) Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity. Neurology 64:1968\u20131970","journal-title":"Neurology"},{"key":"167_CR23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00314245","volume":"255","author":"R Mantegazza","year":"1988","unstructured":"Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F (1988) Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol 255:449\u2013453","journal-title":"J Neurol"},{"key":"167_CR24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s004150050585","volume":"247","author":"T Sharshar","year":"2000","unstructured":"Sharshar T, Chevret S, Mazighi M, Chillet P, Huberfeld G, Berreotta C, Houfani M, Gajdos P (2000) Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis. J Neurol 247:286\u2013290","journal-title":"J Neurol"},{"key":"167_CR25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin LR, Nations SP, Foster B, Bryan WW, Barohn RJ (1999) Myasthenia gravis activities of daily living profile. Neurology 52:1487\u20131489","journal-title":"Neurology"},{"key":"167_CR26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2007.02.013","volume":"17","author":"L Vanderveldea","year":"2007","unstructured":"Vanderveldea L, Van den Bergh PYK, Goemans N, Thonnard JL (2007) ACTIVLIM: a Rash-built measure of activity limitations in children and adults with neuromuscular disorders. Neuromuscul Disord 17:459\u2013469","journal-title":"Neuromuscul Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-009-0167-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0167-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:11:42Z","timestamp":1559121102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-009-0167-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1007\/s10072-009-0167-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,9]]}}}